Not applicableLooking for participantsNCT06542484What this trial is testingThe Real-world Treatment Satisfaction by Gefapixiant in RCCWho this might be right forChronic Cough Nagoya City University 63
Early research (Phase 1)WithdrawnNCT03752138What this trial is testingTK216 and Decitabine in Treating Patients With Relapsed and Refractory Acute Myeloid LeukemiaWho this might be right forRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia M.D. Anderson Cancer Center
Very early researchStudy completedNCT03281811What this trial is testingPhotodynamic Therapy in Treating Patients With Refractory Mycosis FungoidesWho this might be right forRefractory Mycosis Fungoides Mayo Clinic 11
Early research (Phase 1)Study completedNCT04139434What this trial is testingDose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AMLWho this might be right forAML/MDSCMMLRelapse+3 more Newave Pharmaceutical Inc 32
Testing effectiveness (Phase 2)Study completedNCT00295932What this trial is testingBortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Memorial Sloan Kettering Cancer Center 79
Testing effectiveness (Phase 2)Ended earlyNCT01383447What this trial is testingEntinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaWho this might be right forPhiladelphia Chromosome Positive Adult Precursor Acute Lymphoblastic LeukemiaRecurrent Adult Acute Lymphoblastic Leukemia National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Study completedNCT00319748What this trial is testingStudy of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical CancersWho this might be right forBreast CancerOvarian CancerEndometrial Cancer+1 more Masonic Cancer Center, University of Minnesota 15
Large-scale testing (Phase 3)Study completedNCT00297947What this trial is testingHigh Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective DisorderWho this might be right forSchizophreniaSchizoaffective Disorder Manhattan Psychiatric Center 60
Testing effectiveness (Phase 2)Study completedNCT00429949What this trial is testingA Phase II Study of Dasatinib in the Treatment of Relapsed or Plateau Phase Multiple MyelomaWho this might be right forRelapsed, Refractory or Plateau Phase Multiple Myeloma Washington University School of Medicine 21
Early research (Phase 1)Active Not RecruitingNCT03635632What this trial is testingC7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)Who this might be right forRelapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+4 more Baylor College of Medicine 94
Testing effectiveness (Phase 2)Ended earlyNCT00003498What this trial is testingAntineoplaston Therapy in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forNon Hodgkin Lymphoma Burzynski Research Institute 5
Large-scale testing (Phase 3)UnknownNCT03298698What this trial is testingEfficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic SyndromeWho this might be right forIdiopathic Nephrotic SyndromeMinimal Change DiseaseFocal Segmental Glomerulosclerosis Radboud University Medical Center 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07327411What this trial is testingCetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid TumorsWho this might be right forAdvanced Refractory Solid Tumors Second Affiliated Hospital of Soochow University 40
Early research (Phase 1)WithdrawnNCT05655598What this trial is testingTAS-116 Plus Palbociclib in Breast and Rb-null CancerWho this might be right forAdvanced Breast CancerTreatment-Refractory Solid TumorsRetinoblastoma Deficiency+4 more Brown University
Testing effectiveness (Phase 2)Study completedNCT01088984What this trial is testingStudy of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute LeukemiaWho this might be right forLeukemia Teva Branded Pharmaceutical Products R&D, Inc. 43
Testing effectiveness (Phase 2)Looking for participantsNCT06561152What this trial is testingTagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AMLWho this might be right forRefractory Acute Myeloid LeukemiaRelapsed Acute Myeloid Leukemia Stanford University 20
Not applicableStudy completedNCT04479787What this trial is testingSpinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT)Who this might be right forChronic Low-Back PainRefractory PainNeuropathic Pain Abbott Medical Devices 270
Very early researchStudy completedNCT04256733What this trial is testingCough Desensitization Therapy for Cough Hypersensitivity SyndromeWho this might be right forCough University of Montana 19
Testing effectiveness (Phase 2)Study completedNCT00901147What this trial is testingStudy of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell LymphomaWho this might be right forPeripheral T-cell Lymphoma (Not Otherwise Specified)Angioimmunoblastic T-cell LymphomaExtranodal NK/T-cell Lymphoma Nasal Type+4 more Singapore General Hospital 25
Large-scale testing (Phase 3)UnknownNCT02532738What this trial is testingThe Efficiency of MSC in Refractory Crohn's DiseaseWho this might be right forCrohn's Disease Sixth Affiliated Hospital, Sun Yat-sen University 3